Palvella Therapeutics (PVLA) Capital Expenditures Growth (1y) (2015 - 2023)
Palvella Therapeutics (PVLA) Capital Expenditures Growth (1y) (2015 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Palvella Therapeutics |
1.42 Bn |
1.16 Bn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
-118.22% |
| Sep 30, 2023 |
587.50% |
| Jun 30, 2023 |
109.19% |
| Mar 31, 2023 |
-83.89% |
| Dec 31, 2022 |
6.43% |
| Sep 30, 2022 |
106.23% |
| Jun 30, 2022 |
-223.58% |
| Mar 31, 2022 |
964.29% |
| Dec 31, 2021 |
64.19% |
| Sep 30, 2021 |
69.40% |
| Jun 30, 2021 |
-78.42% |
| Mar 31, 2021 |
-98.55% |
| Dec 31, 2020 |
-50.85% |
| Sep 30, 2020 |
-462.07% |
| Jun 30, 2020 |
13.72% |
| Mar 31, 2020 |
1,492.56% |
| Dec 31, 2019 |
108.14% |
| Sep 30, 2019 |
-28.62% |
| Jun 30, 2019 |
136.80% |
| Mar 31, 2019 |
-70.77% |
